2 assets in Acoustic Neuroma

Therapeutic assets addressing Acoustic Neuroma, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Rvp-001 Acoustic Neuroma	Reveal Pharmaceuticals Inc.	P2	B (57)
Panitumumab-Irdye800 Acoustic Neuroma	Eben Rosenthal	Early P1	C (39)